Use of Chemical Chaperones in the Yeast Saccharomyces cerevisiae to Enhance Heterologous Membrane Protein Expression: High-Yield Expression and Purification of Human P-Glycoprotein
Identifieur interne : 000F76 ( Istex/Checkpoint ); précédent : 000F75; suivant : 000F77Use of Chemical Chaperones in the Yeast Saccharomyces cerevisiae to Enhance Heterologous Membrane Protein Expression: High-Yield Expression and Purification of Human P-Glycoprotein
Auteurs : Robert A. Figler ; Hiroshi Omote ; Robert K. Nakamoto ; Marwan K. Al-ShawiSource :
- Archives of Biochemistry and Biophysics [ 0003-9861 ] ; 2000.
English descriptors
- KwdEn :
- Teeft :
- Academic press, Active form, Assay, Assay conditions, Atpase, Atpase activities, Atpase activity, Bamhi site, Basal, Basal activity, Basal atpase activity, Biol, Blot analysis, Bovine brain phosphatidylserine, Carbon source, Carolyn slayman, Cell biol, Cell growth, Cerevisiae, Chaperone, Chem, Chemical chaperone, Chemical chaperone glycerol, Chemical chaperones, Codon, Coli, Coli lipid vesicles, Constant agitation, Constitutive, Constitutive pma1 promoter region, Control cells, Control experiments, Control plasmid, Control yeast strain, Dimethyl sulfoxide, Drug activation, Ecori cassette, Egta, Expression level, Expression levels, Expression plasmid yepgalmdr1, Expression yeast strain, Figler, Functional expression, Gal1, Gal1 promoter, Galactose plate, Glucose, Glycerol, Gottesman, Growth characteristics, Growth media, Growth yields, Heterologous, Heterologous expression, High levels, High yields, Human pglycoprotein, Initiation codon, Kinetic constants, Leu2 episomal plasmid, Lipid, Lipid composition, Lipid proteoliposomes, Lipid stock, Lipid vesicles, Maximal value, Mdr1, Mdr1 cdna, Membrane, Membrane proteins, Methods enzymol, Microsome, Milligram quantities, Monoclonal antibody, Multidrug resistance, Mutant, Mutant forms, Open reading frame, Optical density, Optimal concentration, Other hand, Pichia pastoris, Plasma membrane, Plasma membranes, Plasmid, Pma1, Pma1 expression, Pma1 promoter, Pma1 transcriptional termination sequence, Pma1 transcriptional termination sequence leu2 episomal plasmid, Pmsf, Primary antibody, Promoter, Promoter region, Protein level, Proteoliposomes, Proteolytic degradation, Psti fragment, Rapid drop, Rapid turnover, Reading frame, Reconstituted, Reconstitution, Relative levels, Restriction mapping, Saccharomyces cerevisiae, Same level, Single band, Solubilization buffer, Solubilized, Solubilized membranes, Stationary phase, Strong constitutive pma1 promoter, Structural studies, Termination codon, Tissue culture, Total membrane protein, Transformants, Transport proteins, Transport substrates, Transporter, Tris base, Unpublished results, Valinomycin, Valinomycin activation, Verapamil, Vesicle, Yale university, Yeast, Yeast cell fractions, Yeast cells, Yeast expression, Yeast homologs, Yeast membranes, Yeast plasma membrane, Yeast plasma membranes, Yeast strains, Yepgalmdr1, Yepmdr1his.
Abstract
Abstract: Utilizing human P-glycoprotein (P-gp), we investigated methods to enhance the heterologous expression of ATP-binding cassette transporters in Saccharomyces cerevisiae. Human multidrug resistance gene MDR1 cDNA was placed in a high-copy 2μ yeast expression plasmid under the control of the inducible GAL1 promoter or the strong constitutive PMA1 promoter from which P-gp was expressed in functional form. Yeast cells expressing P-gp were valinomycin resistant. Basal ATPase activity of P-gp in yeast membranes was 0.4–0.7 μmol/mg/min indicating excellent functionality. P-glycoprotein expressed in the protease-deficient strain BJ5457 was found in the plasma membrane and was not N-glycosylated. By use of the PMA1 promoter, P-gp could be expressed at 3% of total membrane protein. The expression level could be further enhanced to 8% when cells were grown in the presence of 10% glycerol as a chemical chaperone. Similarly, glycerol enhanced protein levels of P-gp expressed under control of the GAL1 promoter. Glycerol was demonstrated to enhance posttranslational stability of P-gp. Polyhistidine-tagged P-gp was purified by metal affinity chromatography and reconstituted into proteoliposomes in milligram quantities and its ATPase activity was characterized. Turnover numbers as high as 12 s−1 were observed. The kinetic parameters KMgATPM, Vmax, and drug activation were dependent on the lipid composition of proteoliposomes and pH of the assay and were similar to P-gp purified from mammalian sources. In conclusion, we developed a system for cost-effective, high-yield, heterologous expression of functional P-gp useful in producing large quantities of normal and mutant P-gp forms for structural and mechanistic studies.
Url:
DOI: 10.1006/abbi.2000.1712
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
ISTEX:2D3D9D818C527204D94CC9FF1885D78DEDAD4702Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Use of Chemical Chaperones in the Yeast Saccharomyces cerevisiae to Enhance Heterologous Membrane Protein Expression: High-Yield Expression and Purification of Human P-Glycoprotein</title>
<author><name sortKey="Figler, Robert A" sort="Figler, Robert A" uniqKey="Figler R" first="Robert A." last="Figler">Robert A. Figler</name>
</author>
<author><name sortKey="Omote, Hiroshi" sort="Omote, Hiroshi" uniqKey="Omote H" first="Hiroshi" last="Omote">Hiroshi Omote</name>
</author>
<author><name sortKey="Nakamoto, Robert K" sort="Nakamoto, Robert K" uniqKey="Nakamoto R" first="Robert K." last="Nakamoto">Robert K. Nakamoto</name>
</author>
<author><name sortKey="Al Shawi, Marwan K" sort="Al Shawi, Marwan K" uniqKey="Al Shawi M" first="Marwan K." last="Al-Shawi">Marwan K. Al-Shawi</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:2D3D9D818C527204D94CC9FF1885D78DEDAD4702</idno>
<date when="2000" year="2000">2000</date>
<idno type="doi">10.1006/abbi.2000.1712</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-4T8G8FFT-G/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002607</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002607</idno>
<idno type="wicri:Area/Istex/Curation">002607</idno>
<idno type="wicri:Area/Istex/Checkpoint">000F76</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000F76</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Use of Chemical Chaperones in the Yeast Saccharomyces cerevisiae to Enhance Heterologous Membrane Protein Expression: High-Yield Expression and Purification of Human P-Glycoprotein</title>
<author><name sortKey="Figler, Robert A" sort="Figler, Robert A" uniqKey="Figler R" first="Robert A." last="Figler">Robert A. Figler</name>
<affiliation><wicri:noCountry code="subField">22908-0736</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Omote, Hiroshi" sort="Omote, Hiroshi" uniqKey="Omote H" first="Hiroshi" last="Omote">Hiroshi Omote</name>
<affiliation><wicri:noCountry code="subField">22908-0736</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Nakamoto, Robert K" sort="Nakamoto, Robert K" uniqKey="Nakamoto R" first="Robert K." last="Nakamoto">Robert K. Nakamoto</name>
<affiliation><wicri:noCountry code="subField">22908-0736</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Al Shawi, Marwan K" sort="Al Shawi, Marwan K" uniqKey="Al Shawi M" first="Marwan K." last="Al-Shawi">Marwan K. Al-Shawi</name>
<affiliation><wicri:noCountry code="subField">22908-0736</wicri:noCountry>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Archives of Biochemistry and Biophysics</title>
<title level="j" type="abbrev">YABBI</title>
<idno type="ISSN">0003-9861</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="2000">2000</date>
<biblScope unit="volume">376</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="34">34</biblScope>
<biblScope unit="page" to="46">46</biblScope>
</imprint>
<idno type="ISSN">0003-9861</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0003-9861</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>ABC transporters</term>
<term>P-glycoprotein</term>
<term>Saccharomyces cerevisiae</term>
<term>chemical chaperones</term>
<term>glycerol</term>
<term>heterologous expression</term>
<term>membrane proteins</term>
<term>yeast</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Academic press</term>
<term>Active form</term>
<term>Assay</term>
<term>Assay conditions</term>
<term>Atpase</term>
<term>Atpase activities</term>
<term>Atpase activity</term>
<term>Bamhi site</term>
<term>Basal</term>
<term>Basal activity</term>
<term>Basal atpase activity</term>
<term>Biol</term>
<term>Blot analysis</term>
<term>Bovine brain phosphatidylserine</term>
<term>Carbon source</term>
<term>Carolyn slayman</term>
<term>Cell biol</term>
<term>Cell growth</term>
<term>Cerevisiae</term>
<term>Chaperone</term>
<term>Chem</term>
<term>Chemical chaperone</term>
<term>Chemical chaperone glycerol</term>
<term>Chemical chaperones</term>
<term>Codon</term>
<term>Coli</term>
<term>Coli lipid vesicles</term>
<term>Constant agitation</term>
<term>Constitutive</term>
<term>Constitutive pma1 promoter region</term>
<term>Control cells</term>
<term>Control experiments</term>
<term>Control plasmid</term>
<term>Control yeast strain</term>
<term>Dimethyl sulfoxide</term>
<term>Drug activation</term>
<term>Ecori cassette</term>
<term>Egta</term>
<term>Expression level</term>
<term>Expression levels</term>
<term>Expression plasmid yepgalmdr1</term>
<term>Expression yeast strain</term>
<term>Figler</term>
<term>Functional expression</term>
<term>Gal1</term>
<term>Gal1 promoter</term>
<term>Galactose plate</term>
<term>Glucose</term>
<term>Glycerol</term>
<term>Gottesman</term>
<term>Growth characteristics</term>
<term>Growth media</term>
<term>Growth yields</term>
<term>Heterologous</term>
<term>Heterologous expression</term>
<term>High levels</term>
<term>High yields</term>
<term>Human pglycoprotein</term>
<term>Initiation codon</term>
<term>Kinetic constants</term>
<term>Leu2 episomal plasmid</term>
<term>Lipid</term>
<term>Lipid composition</term>
<term>Lipid proteoliposomes</term>
<term>Lipid stock</term>
<term>Lipid vesicles</term>
<term>Maximal value</term>
<term>Mdr1</term>
<term>Mdr1 cdna</term>
<term>Membrane</term>
<term>Membrane proteins</term>
<term>Methods enzymol</term>
<term>Microsome</term>
<term>Milligram quantities</term>
<term>Monoclonal antibody</term>
<term>Multidrug resistance</term>
<term>Mutant</term>
<term>Mutant forms</term>
<term>Open reading frame</term>
<term>Optical density</term>
<term>Optimal concentration</term>
<term>Other hand</term>
<term>Pichia pastoris</term>
<term>Plasma membrane</term>
<term>Plasma membranes</term>
<term>Plasmid</term>
<term>Pma1</term>
<term>Pma1 expression</term>
<term>Pma1 promoter</term>
<term>Pma1 transcriptional termination sequence</term>
<term>Pma1 transcriptional termination sequence leu2 episomal plasmid</term>
<term>Pmsf</term>
<term>Primary antibody</term>
<term>Promoter</term>
<term>Promoter region</term>
<term>Protein level</term>
<term>Proteoliposomes</term>
<term>Proteolytic degradation</term>
<term>Psti fragment</term>
<term>Rapid drop</term>
<term>Rapid turnover</term>
<term>Reading frame</term>
<term>Reconstituted</term>
<term>Reconstitution</term>
<term>Relative levels</term>
<term>Restriction mapping</term>
<term>Saccharomyces cerevisiae</term>
<term>Same level</term>
<term>Single band</term>
<term>Solubilization buffer</term>
<term>Solubilized</term>
<term>Solubilized membranes</term>
<term>Stationary phase</term>
<term>Strong constitutive pma1 promoter</term>
<term>Structural studies</term>
<term>Termination codon</term>
<term>Tissue culture</term>
<term>Total membrane protein</term>
<term>Transformants</term>
<term>Transport proteins</term>
<term>Transport substrates</term>
<term>Transporter</term>
<term>Tris base</term>
<term>Unpublished results</term>
<term>Valinomycin</term>
<term>Valinomycin activation</term>
<term>Verapamil</term>
<term>Vesicle</term>
<term>Yale university</term>
<term>Yeast</term>
<term>Yeast cell fractions</term>
<term>Yeast cells</term>
<term>Yeast expression</term>
<term>Yeast homologs</term>
<term>Yeast membranes</term>
<term>Yeast plasma membrane</term>
<term>Yeast plasma membranes</term>
<term>Yeast strains</term>
<term>Yepgalmdr1</term>
<term>Yepmdr1his</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Abstract: Utilizing human P-glycoprotein (P-gp), we investigated methods to enhance the heterologous expression of ATP-binding cassette transporters in Saccharomyces cerevisiae. Human multidrug resistance gene MDR1 cDNA was placed in a high-copy 2μ yeast expression plasmid under the control of the inducible GAL1 promoter or the strong constitutive PMA1 promoter from which P-gp was expressed in functional form. Yeast cells expressing P-gp were valinomycin resistant. Basal ATPase activity of P-gp in yeast membranes was 0.4–0.7 μmol/mg/min indicating excellent functionality. P-glycoprotein expressed in the protease-deficient strain BJ5457 was found in the plasma membrane and was not N-glycosylated. By use of the PMA1 promoter, P-gp could be expressed at 3% of total membrane protein. The expression level could be further enhanced to 8% when cells were grown in the presence of 10% glycerol as a chemical chaperone. Similarly, glycerol enhanced protein levels of P-gp expressed under control of the GAL1 promoter. Glycerol was demonstrated to enhance posttranslational stability of P-gp. Polyhistidine-tagged P-gp was purified by metal affinity chromatography and reconstituted into proteoliposomes in milligram quantities and its ATPase activity was characterized. Turnover numbers as high as 12 s−1 were observed. The kinetic parameters KMgATPM, Vmax, and drug activation were dependent on the lipid composition of proteoliposomes and pH of the assay and were similar to P-gp purified from mammalian sources. In conclusion, we developed a system for cost-effective, high-yield, heterologous expression of functional P-gp useful in producing large quantities of normal and mutant P-gp forms for structural and mechanistic studies.</div>
</front>
</TEI>
<affiliations><list></list>
<tree><noCountry><name sortKey="Al Shawi, Marwan K" sort="Al Shawi, Marwan K" uniqKey="Al Shawi M" first="Marwan K." last="Al-Shawi">Marwan K. Al-Shawi</name>
<name sortKey="Figler, Robert A" sort="Figler, Robert A" uniqKey="Figler R" first="Robert A." last="Figler">Robert A. Figler</name>
<name sortKey="Nakamoto, Robert K" sort="Nakamoto, Robert K" uniqKey="Nakamoto R" first="Robert K." last="Nakamoto">Robert K. Nakamoto</name>
<name sortKey="Omote, Hiroshi" sort="Omote, Hiroshi" uniqKey="Omote H" first="Hiroshi" last="Omote">Hiroshi Omote</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Istex/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F76 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd -nk 000F76 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= Istex |étape= Checkpoint |type= RBID |clé= ISTEX:2D3D9D818C527204D94CC9FF1885D78DEDAD4702 |texte= Use of Chemical Chaperones in the Yeast Saccharomyces cerevisiae to Enhance Heterologous Membrane Protein Expression: High-Yield Expression and Purification of Human P-Glycoprotein }}
This area was generated with Dilib version V0.6.33. |